基于深度学习预测肺癌患者射波刀蒙特卡罗计划剂量:可变射束配置的稳健学习
本研究基于3D U-Net网络,比较纳入射束编码信息的AB模型与仅用解剖信息的Mask模型,对86例接受射波刀内置蒙特卡罗算法计划的肺癌患者进行剂量预测。AB模型在部分剂量区域Dice相似系数较Mask模型高20–40%,伽马通过率在PTV约99%、危及器官一般超过95%(3 mm/3%),所有器官平均剂量误差为1.65 ± 0.69%。
要点
- AB模型在射束轨迹剂量上优于仅用解剖信息的Mask模型。
- 伽马通过率(3 mm/3%)PTV约99%,危及器官一般超过95%。
- 所有器官平均剂量误差为1.65 ± 0.69%。
核心结论
- 作者提出的新模型在预测射波刀三维剂量分布方面是临床应用的重要进展,使计划者能基于患者特异性射束配置快速准确预测肺癌蒙特卡罗剂量并优化治疗流程。
研究设计与样本
- 研究收集86例接受射波刀内置蒙特卡罗算法计划、使用不同射束配置的肺癌患者,其中66例用于训练/验证、20例用于测试。
- 研究提出将AB(解剖与射束)模型与对照Mask(仅解剖)模型进行比较,两者均基于3D U-Net网络,以探讨射波刀射束编码信息对剂量预测的影响。
主要发现
- AB模型表现优于Mask模型,尤其在射束轨迹剂量方面。
- AB模型在某些剂量区域的Dice相似系数较Mask模型高20–40%。
- 以临床计划剂量为参考,伽马通过率(3 mm/3%)在PTV约99%,危及器官一般超过95%。
- 相对Mask模型,AB模型在小体素方面改善超过90%(p < 0.001)。
- AB模型与临床计划的剂量体积直方图匹配良好,所有器官平均剂量误差为1.65 ± 0.69%。
关键数值与推荐
- 研究采用伽马通过率(3 mm/3%)、剂量差异图和相关剂量体积指标比较模型性能。
- 研究计算Dice相似系数以评估等剂量体积的空间对应性。
临床怎么用
- 作者认为该模型使计划者能基于患者特异性射束配置快速准确预测肺癌的蒙特卡罗剂量,并优化射波刀治疗流程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate calculation of lung cancer dose using the Monte Carlo (MC) algorithm in CyberKnife (CK) is essential for precise planning. We aim to employ deep learning to directly predict the 3D dose distribution calculated by the MC algorithm, enabling rapid and accurate automatic planning. However, most current methods solely focus on conventional intensity-modulated radiation therapy and assume a consistent beam configuration across all patients. This study seeks to develop a more versatile model incorporating variable beam configurations of CK and considering the patient's anatomy. METHODS: This study proposed that the AB (anatomy and beam) model be compared with the control Mask (only anatomy) model. These models are based on a 3D U-Net network to investigate the impact of CK beam encoding information on dose prediction. The study collected 86 lung cancer patients who received CK's built-in MC algorithm plans using different beam configurations for training/validation (66 cases) and testing (20 cases). We compared the gamma passing rate, dose difference maps, and relevant dose-volume metrics to evaluate the model's performance. In addition, the Dice similarity coefficients (DSCs) were calculated to assess the spatial correspondence of isodose volumes. RESULTS: The AB model demonstrated superior performance compared to the Mask model, particularly in the trajectory dose of the beam. The DSCs of the AB model were 20-40% higher than that of the Mask model in some dose regions. We achieved approximately 99% for the PTV and generally more than 95% for the organs at risk (OARs) referred to the clinical planning dose in the gamma passing rates (3 mm/3%). Relative to the Mask model, the AB model exhibited more than 90% improvement in small voxels (p < 0.001). The AB model matched well with the clinical plan's dose-volume histograms, and the average dose error for all organs was 1.65 ± 0.69%. CONCLUSIONS: Our proposed new model signifies a crucial advancement in predicting CK 3D dose distributions for clinical applications. It enables planners to rapidly and precisely predict MC doses for lung cancer based on patient-specific beam configurations and optimize the CK treatment process.
引用
- Miao Y, Li J, Ge R, et al. Dose prediction of CyberKnife Monte Carlo plan for lung cancer patients based on deep learning: robust learning of variable beam configurations. Radiat Oncol. 2024. PMID: 39587661. doi:10.1186/s13014-024-02531-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。